Impact of Moderate Preterm Birth on Vocabulary Acquisition
- Disease/Condition
- Premature Birth
- Drug/Device/Intervention
- Electroencephalography
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Assistance Publique Hopitaux De Marseille
- Location
- Marseille, France
- Phase
- N/A
- Start date
- Oct 19, 2022
- End date
- Oct 18, 2027
- Enrollment
- 160 participants
Study the impact of moderate prematurity on speech encoding characteristics development,Study the impact of moderate prematurity on speech encoding characteristics development,Study the impact of moderate prematurity on speech encoding characteristics development,Study the impact of moderate prematurity on speech encoding characteristics development,Study the impact of moderate prematurity on speech encoding characteristics development,Study the impact of moderate prematurity on speech encoding characteristics development
Children born prematurely may present a neurodevelopmental disorder with a language delay
 diagnosed as early as 2-3 years of age. This situation is not uncommon: each year in France,
 approximately 35,000 children are born between 32 and 36 weeks of amenorrhea.
 
 In our most recent work, we have shown that moderate premature infants show an attenuated
 cortical response to a vowel change, suggesting a deficit in the cortical encoding of vowels.
 This work needs to be continued in order to better understand syllable encoding and identify
 the neuroplasticity mechanisms underlying early speech encoding.
 
 The identification of markers to predict language development is essential for the screening
 of these children at risk of language delay. These children could thus benefit from early
 adapted care even before the appearance of language deficits.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05397197
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05397197 through Pure Global AI's free database. This phase not specified trial is sponsored by Assistance Publique Hopitaux De Marseille and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 160 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.